Clinical trials: Soft Tissue
Breast Cancer, Soft Tissue Sarcoma
Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer
The purpose of this study is to determine whether treatment with temozolomide can effect the survival of patients with advanced breast cancer or soft tissue sarcoma.
- Trial name
- NCT00194766
- Testing
- Temozolomide
- Where
- United States
- Volunteers
- 35 people
- Sponsor
- University of Washington
Sarcoma, Soft Tissue
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
The purpose of this study is to compare the drug gemcitabine to two drugs, gemcitabine and docetaxel, to find out which treatment is better for people with sarcomas.
- Trial name
- NCT00142571
- Testing
- Gemcitabine, Docetaxel
- Where
- United States
- Volunteers
- 120 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Soft Tissue Sarcoma
Study of Low Dose CT in Sarcoma Patients
The primary outcome of this study is the detection of lung metastases comparing Low dose CT (LDCT) and Minimum dose CT (MnDCT) with CXR. Hypothesis 1.
- Trial name
- NCT00188422
- Testing
- low dose CT
- Where
- Canada
- Volunteers
- 70 people
- Sponsor
- University Health Network, Toronto
Sarcoma, Soft Tissue
Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
The aims of this trial are to evaluate the efficacy of bendamustin in patients with metastatic soft tissue sarcoma who have progressed after or during an anthracycline-baesd chemotherapy and to assess the treatment of toxicity.
- Trial name
- NCT00204620
- Testing
- Bendamustin
- Where
- Germany
- Volunteers
- 28 people
- Sponsor
- University Hospital Tuebingen
Sarcoma, Soft Tissue
Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Complete resection is still the only curative treatment option in patients with soft tissue sarcoma (STS). Patients with a non-resectable STS have a dismal prognosis even without evidence of metastatic disease.
- Trial name
- NCT00204646
- Testing
- Adriamycin, Ifosfamide, Etoposide
- Where
- Germany
- Sponsor
- University Hospital Tuebingen
Rhabdomyosarcomas, Neoplasms, Connective and Soft Tissue
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
This is a phase II study to determine the antitumor activity of Vinorelbine and Cyclofosfamide association among patients with refractory tumours or in relapse with rhabdomyosarcomas and other soft tissue tumours, Ewing tumours…
- Conditions
- Rhabdomyosarcomas, Neoplasms, Connective and Soft Tissue, Ewing Tumor, Osteosarcomas
- Trial name
- NCT00180947
- Testing
- Vinorelbine, cyclofosfamide
- Where
- France
- Volunteers
- 210 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
Soft Tissue Sarcoma
A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
The purpose of this study is to evaluate the safety and effectiveness of an experimental study drug (STA-4783) combined with an approved cancer medicine, paclitaxel, in the treatment of soft tissue sarcomas.
- Trial name
- NCT00087997
- Testing
- STA-4783
- Where
- 27 sites in United States, Canada
- Volunteers
- 80 people
- Sponsor
- Synta Pharmaceuticals Corp.
Advanced Metastastic Malignant Melanoma, Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
The incidence of malignant melanoma continues to rise throughout the world. Approximately 12 in 100,000 Germans are diagnosed with malignant melanoma per year.
- Trial name
- NCT00264056
- Testing
- hyperthermia
- Where
- Germany
- Volunteers
- 26 people
- Sponsor
- Fachklinik Hornheide an der Universität Münster
Soft Tissue Neoplasms
Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
Retrospective review of clinical outcome of pediatric Dermatofibrosarcoma Protuberans (PDFSP) after active invitation
- Trial name
- NCT00173355
- Where
- Taiwan
- Volunteers
- 12 people
- Sponsor
- National Taiwan University Hospital
Soft Tissue Anesthesia (Numbness)
Safety and Efficacy Study of NV-101 in Dental Patients
The purpose of this study was: to determine if NV-101 accelerates recovery from numbness compared to placebo to evaluate safety of NV-101
- Trial name
- NCT00154167
- Testing
- NV-101 (phentolamine mesylate solution)
- Where
- United States
- Volunteers
- 122 people, healthy volunteers welcome
- Sponsor
- Novalar Pharmaceuticals, Inc.
Rhabdomyosarcoma, Malignant Soft Tissue
Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
Objective of the study objectives was to explore survival advantage for an intensified chemotherapy strategy in a randomised trial.
- Trial name
- NCT00162695
- Testing
- Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide
- Where
- France
- Volunteers
- 400 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris